Community Medical Services

Changes are coming to Medicaid programs across the country because of a federal law passed in 2025, commonly referred to as H.R. 1 or the "One Big Beautiful Bill." Because these changes are complex, will take effect at different times in different states,

At the conclusion of every year, we sit down as a company and ask a simple question: did we actually help people this year? The CMS 2025 Patient Outcomes Report is our attempt to answer that honestly with data, not just good intentions. Here's what it tol

Community Medical Services is pleased to announce that most CMS locations now accept eligible Cigna insurance plans for opioid use disorder treatment and related recovery services. This update gives more individuals and families another potential way to a

When you hear the words "opioid use disorder," what comes to mind? For too many people, the answer is shaped by stigma: assumptions, fear, judgment, or the belief that addiction is simply a matter of choice or willpower. But opioid use disorder, or OUD, i

The federal government has taken its first concrete regulatory step against a group of lab-made kratom-derived compounds. At Community Medical Services (CMS), we know that headlines like this one raise real, personal questions for people who use these pro

Opioid treatment programs (OTPs) are designed to help people recover from opioid addiction, yet many patients find themselves frustrated by unnecessary barriers, inadequate care, and a lack of compassion in these programs. Stories from patients switching

The U.S. Drug Enforcement Administration has taken a major step toward removing dangerous concentrated synthetic 7-hydroxymitragynine (7-OH) products from store shelves. If you or someone you love has been using these products, this news matters, not just

For many patients, the short answer is yes. In general, breastfeeding is encouraged for mothers who are stable on methadone treatment for opioid use disorder and who do not have another medical reason to avoid breastfeeding. Major clinical guidance from A